InvestorsHub Logo
Followers 0
Posts 1326
Boards Moderated 0
Alias Born 01/25/2016

Re: Cherrypoppers post# 47494

Wednesday, 06/10/2020 8:15:39 AM

Wednesday, June 10, 2020 8:15:39 AM

Post# of 113741
Wheres the batch of the drug??


Line from every filing....We have been delayed in our clinical development program due to lack of funding. Our fund raising efforts are continuing and as soon as adequate financing is in place we will continue our clinical development program of Adva-27a by conducting the following next sequence of steps:

 

?

GMP Manufacturing of 2 kilogram for use in IND-Enabling Studies and Phase I Clinical Trials

?

IND-Enabling Studies

?

Regulatory Filing (Fast-Track Status Anticipated)

?

Phase I Clinical Trials (Pancreatic Cancer Indication)

Here's where they are according to their own filings....ive yet to see any progress here......never once seen a filing indicating a sample batch met the requirements. In lonza couldnt do it, no one can. Simple.

From the filing.....

On November 14, 2014, we entered into a Manufacturing Services Agreement with Lonza Ltd. and Lonza Sales Ltd. (hereinafter jointly referred to as “Lonza”), whereby we engaged Lonza to be the manufacturer of our Adva-27a anticancer drug. In June 2015 we received a sample of the pilot manufacturing run for evaluation. Our laboratory analyses showed that, while the sample meets all of the required chemical, physical and biological specifications, the amount of material generated (the “Yield”) by the pilot run was found to be significantly lower than anticipated. We are currently working towards finding possible solutions to increase the Yield and define a path forward. During the course of our discussions concerning the problem of the low Yield, Lonza informed us that they required us to pay them $687,818 prior to moving forward with any activity pertaining to the manufacturing agreement we have with them. We have repeatedly indicated to Lonza that a clear path defining exactly how the extremely low Yield issue would be addressed is imperative prior to us making any payments. As of the date of this report, neither party has changed its position. See “Part I, Item 3 – Legal Proceedings.”

You're getting scammed. Adva27a is a failure. They tried. Didn't work probably why the french institute of sciences sold the patents.

All IMO.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News